
Medline Inc.: updates and filings
Price
$39.16
November 18, 2026Market cap $31.7B
What Ploutos Investor adds for Medline
Part of Ploutos Investor, €9.99 a month
- The full history: 3 fiscal years, from 2023
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 4, 2026next Feb 8, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
October 2026
August 2026
June 2026
May 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 18, 2026Material agreement entered, other material eventsForm8-K
- Nov 17, 2026FilingFormEFFECT
- Nov 16, 2026FilingFormS-1
- Nov 13, 2026Filing (amendment)Form144/A
- Nov 13, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Nov 6, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 4, 2026Quarterly reportfor the period to Sep 26, 2026Form10-Q
- Nov 4, 2026Results of operationsForm8-K
- Oct 30, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Oct 21, 2026Regulation FD disclosureForm8-K
- Oct 15, 2026Officer or director changeForm8-K
- Aug 11, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 7, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 6, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Aug 5, 2026Quarterly reportfor the period to Jun 27, 2026Form10-Q
- Aug 5, 2026Results of operationsForm8-K
- Jul 17, 2026FilingFormDRS
- Jul 9, 2026Officer or director changeForm8-K
- Jun 12, 2026Shareholder voteForm8-K
- Jun 2, 2026Material agreement entered, new material financial obligation, other material eventsForm8-K
- May 21, 2026FilingFormEFFECT
- May 21, 2026FilingFormS-1MEF
- May 20, 2026Correspondence with the SECFormCORRESP
- May 20, 2026FilingFormS-1
- May 15, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 18, 2026 | 8-K | Material agreement entered, other material events | Document |
| Nov 17, 2026 | EFFECT | Filing | Document |
| Nov 16, 2026 | S-1 | Filing | Document |
| Nov 13, 2026 | 144/A | Filing (amendment) | Document |
| Nov 13, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Nov 6, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 4, 2026 | 10-Q | Quarterly reportfor the period to Sep 26, 2026 | Document |
| Nov 4, 2026 | 8-K | Results of operations | Document |
| Oct 30, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Oct 21, 2026 | 8-K | Regulation FD disclosure | Document |
| Oct 15, 2026 | 8-K | Officer or director change | Document |
| Aug 11, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 7, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 6, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Aug 5, 2026 | 10-Q | Quarterly reportfor the period to Jun 27, 2026 | Document |
| Aug 5, 2026 | 8-K | Results of operations | Document |
| Jul 17, 2026 | DRS | Filing | Document |
| Jul 9, 2026 | 8-K | Officer or director change | Document |
| Jun 12, 2026 | 8-K | Shareholder vote | Document |
| Jun 2, 2026 | 8-K | Material agreement entered, new material financial obligation, other material events | Document |
| May 21, 2026 | EFFECT | Filing | Document |
| May 21, 2026 | S-1MEF | Filing | Document |
| May 20, 2026 | CORRESP | Correspondence with the SEC | Document |
| May 20, 2026 | S-1 | Filing | Document |
| May 15, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Dec 19, 2024.
The full analysis
What do Medline's filings show?
The filings are where every one of Medline's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.